Ignite Creation Date:
2024-07-17 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06462781
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-12
Brief Title:
Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment
Sponsor:
The Cooper Health System
Organization:
The Cooper Health System
Study Overview
Official Title:
Intra-Arterial Injection of Lidocaine and Glucocorticoid in the Treatment of Intractable Headaches
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LIGHT
Brief Summary:
The goal of this clinical trial is to test whether injecting lidocaine and steroids into two blood vessels of the brain can help treat chronic headaches migraines
The main questions this study aims to answer are
Is this treatment safe for chronic migraine patients
Is this treatment effective for chronic migraine patients
Participants will
Be treated once with lidocaine and steroid infused into the middle meningeal arteries two blood vessels in the brain
Attend appointments scheduled 1 week 6 weeks and 12 weeks after the treatment for a checkup
Keep a log of their symptoms
The main questions this study aims to answer are
Is this treatment safe for chronic migraine patients
Is this treatment effective for chronic migraine patients
Participants will
Be treated once with lidocaine and steroid infused into the middle meningeal arteries two blood vessels in the brain
Attend appointments scheduled 1 week 6 weeks and 12 weeks after the treatment for a checkup
Keep a log of their symptoms
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None